Futura Medical shares boosted by step-up in investor roadshows

04:51 EDT 4 Jul 2017 | Proactive Investors

Futura Medical PLC (LON:FUM) is stepping up roadshows to highlighting its technology with a presentation to institutional investors today on its topical gel for erectile dysfunction, MED2002. Part of a capital markets event, the presentation is similar to the one used for potential licensing partners and comprises a detailed insight into key aspects of the clinical development and commercial potential of the product. Futura believes MED2002 offers the fastest speed of onset, the least side-effects and the fewest contra-indications of any ED medication. The presentation is available at Shares rose 3% to 53p.

Original Article: Futura Medical shares boosted by step-up in investor roadshows


More From BioPortfolio on "Futura Medical shares boosted by step-up in investor roadshows"

Quick Search


Relevant Topics

Erectile Dysfunction
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to 70. The causes of ED can be both physical and psycholo...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...